Terapia Génica en Enfermedad de Parkinson
PARKBA SAL
Rita
Valenzuela Limiñana
Publications by the researcher in collaboration with Rita Valenzuela Limiñana (8)
2023
-
AT1 receptor autoantibodies mediate effects of metabolic syndrome on dopaminergic vulnerability
Brain, Behavior, and Immunity, Vol. 108, pp. 255-268
2021
-
An ACE2/Mas-related receptor MrgE axis in dopaminergic neuron mitochondria
Redox Biology, Vol. 46
2018
-
Paracrine and Intracrine Angiotensin 1-7/Mas Receptor Axis in the Substantia Nigra of Rodents, Monkeys, and Humans
Molecular Neurobiology, Vol. 55, Núm. 7, pp. 5847-5867
2016
-
Mitochondrial angiotensin receptors in dopaminergic neurons. Role in cell protection and aging-related vulnerability to neurodegeneration
Cell Death and Disease, Vol. 7, Núm. 10
2015
-
Critical period for dopaminergic neuroprotection by hormonal replacement in menopausal rats
Neurobiology of Aging, Vol. 36, Núm. 2, pp. 1194-1208
2013
-
Expression of angiotensinogen and receptors for angiotensin and prorenin in the monkey and human substantia nigra: An intracellular renin-angiotensin system in the nigra
Brain Structure and Function, Vol. 218, Núm. 2, pp. 373-388
2010
-
Estrogen and angiotensin interaction in the substantia nigra. Relevance to postmenopausal Parkinson's disease
Experimental Neurology, Vol. 224, Núm. 2, pp. 517-526
-
Location of prorenin receptors in primate substantia nigra: Effects on dopaminergic cell death
Journal of Neuropathology and Experimental Neurology, Vol. 69, Núm. 11, pp. 1130-1142